Latest News- Dementia And Movement Disorder Treatment Market: Movement disorders is expected to lead the Application segment during 2025-2029

The Dementia And Movement Disorder Treatment Market is being driven by Growing geriatric population

The Dementia And Movement Disorder Treatment Market is expected to grow at a CAGR of 9% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 14429.5 million. The global market for dementia and movement disorder treatments is predominantly driven by the utilization of monoamine oxidase (MAO) inhibitors, acetylcholinesterase (AChE) inhibitors, and glutamate inhibitors. These pharmaceutical interventions are extensively employed for managing various forms of dementia, including Lewy body dementia, and movement disorders, such as Parkinson's disease. Notably, the shared pathological conditions between these diseases, including neurofibrillary tangles, amyloid plaques, and Lewy bodies, necessitate a more nuanced diagnostic approach. Both Lewy body dementia and Parkinson's disease are characterized by cognitive impairment, further complicating their differentiation. 

Get more information on Dementia And Movement Disorder Treatment Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Application
  • Movement disorders
  • Progressive dementia
  • Progressive dementia with neurological abnormality (PDNA)
• Drug Class
  • MAO inhibitors
  • Acetylcholinesterase inhibitors
  • Glutamate inhibitors
  • Others
• Distribution Channel
  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia
    • China
    • India
    • Japan
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Growing geriatric population
• Rising prevalence of target diseases
• Emergence of strategies to increase public awareness

However, the market also witnesses some limitations, which are as follows:

• High cost of neurological disorders treatment
• Failure rates of drugs in clinical trials
• Poor diagnosis of dementia

Benefits of Buying Global Dementia And Movement Disorder Treatment Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Dementia And Movement Disorder Treatment Market Research Report

Request Free Sample

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Dementia and Movement Disorder Treatment Market encompasses various interventions for managing neurodegenerative conditions, including cholinesterase inhibitors and NMDA receptor antagonists. Brain imaging techniques like PET scans and MRI scans, cerebrospinal fluid analysis, genetic testing, and cognitive assessments are utilized for early diagnosis. Functional capacity, caregiver burden, economic impact, and social impact are essential considerations. Psychosocial support, behavioral interventions, environmental modifications, assistive devices, mobility aids, communication aids, adaptive equipment, remote monitoring, and prevention strategies are integral to effective care. Ethical considerations, clinical practice guidelines, and treatment guidelines are crucial in ensuring appropriate end-of-life care. Lifestyle modifications play a significant role in disease management.

Market Research Overview

The Dementia and Movement Disorder Treatment Market encompasses pharmaceutical companies and researchers involved in the development and manufacturing of both generic and non-generic drugs, as well as veterinary medicines. According to Technavio's market analysis, the global pharmaceuticals market's growth is attributed to several factors, including the increasing aging population. By 2050, approximately one-quarter of the US population and Europe's population ratio is projected to be over 60 years old. This demographic shift will escalate the prevalence of neurodegenerative diseases such as Alzheimer's, Parkinson's, and cognitive decline, resulting in a heightened demand for treatments addressing memory impairment, motor dysfunction, and behavioral changes.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/